Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2025-12-24 @ 5:43 PM
NCT ID:
NCT04784468
Eligibility Criteria:
Covid 19 group:
Inclusion Criteria:
* gender: female/male
* age: ≥40 years
* patients admitted at the emergency department
* COVID-19 suspected patients
* able to give written informed consent
Exclusion Criteria:
* children (≤ 18 years) and adults 19-39 years
* not hospitalized, but confirmed COVID-19 patients (outpatients)
* patients without definitive COVID-19 confirmation
Control group:
Inclusion criteria:
* gender: female/male
* age: ≥40 years
* absence of severe illnesses/serious diseases
* able to give written informed consent
Exclusion criteria:
* children (≤ 18 years) and adults 19-39years
* any current or past clinically significant pathology/disease (comorbidity) such as:
* Malignancies
* Cardiovascular diseases
* Diabetes mellitus (I and II)
* Obesity class III (BMI \>40)
* Other severe diseases (e.g. renal, hepatic, thyroid disease, bone metabolic diseases, rheumatoid osteoarthritis, human immunodeficiency syndrome, …)
Influenza group:
Inclusion criteria:
* gender: female/male
* age: ≥40 years
* patients admitted at the emergency department
* influenza suspected patients
* able to give written informed consent
Exclusion criteria:
* children (≤ 18 years) and adults 19-39 years
* patients without definitive influenza confirmation
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT04784468
Study Brief:
Protocol Section:
NCT04784468